PARADIGM BIOCAPITAL ADVISORS LP sold 75.4% of their position (2.40M shares) of OLEMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $35.80M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/5/2024ACC: 0001104659-24-085835
10% Owner
Since Sep 2023
-2.40M
Net shares
Net seller
$35.80M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.40M disposed
Non-Derivative Transactions2
Common Stock, par value $0.0001 per share
Indirect
Shares
−1.87M
Price / share
$14.91
Trade value
$27.90M
% of position
28.4%
8/1/2024
6.59M→4.72M
Common Stock, par value $0.0001 per share
Indirect
Shares
−529.50K
Price / share
$14.91
Trade value
$7.90M
% of position
40.3%
8/1/2024
1.31M→783.12K
Total
Net shares
−2.40M
Net value
-$35.80M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 8/1/2024 | S · Sale | −1.87M | $14.91 | $27.90M | 28.4% | 6.59M | 4.72M |
| Common Stock, par value $0.0001 per share Indirect | 8/1/2024 | S · Sale | −529.50K | $14.91 | $7.90M | 40.3% | 1.31M | 783.12K |
| Total | −2.40M | -$35.80M | ||||||
Derivative Transactions0
No derivative transactions reported